DGS Capital Management LLC Raises Holdings in Colgate-Palmolive (NYSE:CL)

DGS Capital Management LLC raised its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 4.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,001 shares of the company’s stock after purchasing an additional 376 shares during the quarter. DGS Capital Management LLC’s holdings in Colgate-Palmolive were worth $818,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CL. Evergreen Capital Management LLC lifted its position in shares of Colgate-Palmolive by 4.2% during the second quarter. Evergreen Capital Management LLC now owns 3,490 shares of the company’s stock worth $339,000 after purchasing an additional 141 shares in the last quarter. APG Asset Management N.V. increased its stake in Colgate-Palmolive by 64.3% during the 2nd quarter. APG Asset Management N.V. now owns 1,251,422 shares of the company’s stock worth $113,308,000 after buying an additional 489,977 shares during the period. Daymark Wealth Partners LLC lifted its holdings in Colgate-Palmolive by 8.6% during the 2nd quarter. Daymark Wealth Partners LLC now owns 24,553 shares of the company’s stock worth $2,383,000 after buying an additional 1,945 shares in the last quarter. MBB Public Markets I LLC boosted its position in Colgate-Palmolive by 1,530.9% in the 2nd quarter. MBB Public Markets I LLC now owns 56,414 shares of the company’s stock valued at $5,474,000 after buying an additional 52,955 shares during the period. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Colgate-Palmolive by 6.1% in the second quarter. The Manufacturers Life Insurance Company now owns 697,209 shares of the company’s stock worth $67,657,000 after acquiring an additional 39,838 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on CL shares. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Stifel Nicolaus decreased their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. UBS Group decreased their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Finally, Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.11.

Read Our Latest Report on Colgate-Palmolive

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Down 0.0 %

CL stock opened at $87.88 on Friday. The company has a market cap of $71.79 billion, a price-to-earnings ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The company has a fifty day moving average price of $91.93 and a 200 day moving average price of $97.51. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 12 month low of $80.03 and a 12 month high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.